New Drug Application Submitted For Novel Investigational Antibiotic Ceftobiprole (RedNova)
RARITAN, N.J., May 18 /PRNewswire/ -- Johnson

ArthroCare Receives FDA Clearance to Treat Malignant Lesions in the Spine (RedNova)
ArthroCare (Nasdaq:ARTC), a multi-business medical device company that develops minimally invasive surgical products, today announced it has received clearance from the U.S. Food and Drug Administration (FDA) for its Cavity SpineWand to reduce malignant lesions within the vertebrae.

Glenmark gets US FDA marketing nod for pravastatin tabs (PharmaBiz)
Glenmark Pharmaceuticals Ltd, a research-based company has received US FDA approval to market Pravastatin sodium oral tablets 10 mg, 20 mg and 40 mg, a generic version of Bristol Myers Squibb brand Pravachol that has annual sales of over USD 861 million.